Your Unread Messages in Pharma News
See All >> Messages include industry-sponsored communications and special communications from MDLinx1 Senate confirms tavenner as head of CMS Full Text American Pharmacists Association News, May 22, 2013
2 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 Full Text Boston Scientific, May 22, 2013
3 Change in the board of managing directors at Boehringer Ingelheim Full Text Boehringer Ingelheim, May 22, 2013
4 MedeAnalytics Appoints CEO Full Text Healthcare Informatics, May 17, 2013
5 New Leaders at Software Vendor TriZetto Full Text Health Data Management, May 15, 2013
6 New Chief Executive reports Q1 results and sets out strategy for growth Full Text Shire, May 10, 2013
7 Covidien Appoints Jacqueline Strayer Senior Vice President, Corporate Communications Full Text Covidien, May 7, 2013
8 Ready or Not, Here Come HIPAA Audits Full Text Health Data Management, May 6, 2013
9 Top-Tier Insurers Join Mercer Exchange Full Text Health Data Management, May 3, 2013
10 Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer Full Text Teva Pharmaceutical Industries, May 2, 2013
11 Director Declaration Full Text Shire, May 1, 2013
12 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Full Text Teva Pharmaceutical Industries, April 30, 2013
13 Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer Full Text Teva Pharmaceutical Industries, April 30, 2013
14 Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan Full Text Teva Pharmaceutical Industries, April 30, 2013
15 Teva Establishes Global Specialty Medicines Group Full Text Teva Pharmaceutical Industries, April 29, 2013
16 Bristol-Myers Squibb Foundation, Morehouse School of Medicine Partner to Spread Lessons from Together on Diabetes' Initiative Full Text Bristol Myers-Squibb, April 25, 2013
17 Bristol-Myers Squibb Announces Appointment of Francis Cuss as Executive Vice President and Chief Scientific Officer, Effective July 1; Elliott Sigal Plans to Retire Full Text Bristol Myers-Squibb, April 22, 2013
18 Spherix Elects New Independent Director, and Elects Chairman of the Board Full Text Spherix, April 19, 2013
19 Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer Full Text Array BioPharma, April 19, 2013
20 Bristol-Myers Squibb Announces Appointment of Francis Cuss as Executive Vice President and Chief Scientific Officer, Effective July 1; Elliott Sigal Plans to Retire Full Text Bristol Myers-Squibb, April 19, 2013
1 Astellas pharma global development names new head of global regulatory affairs and clinical/research quality assurance Astellas, April 3, 2013 Free full text
2 Bristol-Myers Squibb Announces Appointment of Francis Cuss as Executive Vice President and Chief Scientific Officer, Effective July 1; Elliott Sigal Plans to Retire Bristol Myers-Squibb, April 12, 2013 Free full text
3 Astellas pharma us, inc. names new president Astellas, April 3, 2013 Free full text
4 CoCo Therapeutics Ltd Announces the Appointment of its Clinical and Scientific Advisory Group B3C newswire, March 26, 2013 Free full text
5 Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure Astellas, April 16, 2013 Free full text
6 Dr John LaMattina Joins Ziarco as Strategic Advisor B3C newswire, March 19, 2013 Free full text
7 The Society of Hospital Medicines Choosing Wisely Recommendations for Hospitalists The Hospitalist, March 19, 2013 Free full text
8 Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer Array BioPharma, March 22, 2013 Free full text
9 Spherix Elects New Independent Director, and Elects Chairman of the Board Spherix, April 19, 2013 Free full text
10 Toshiba Names Nancy Gillen Vice President Of Marketing Imaging Economics, April 9, 2013 Free full text
11 Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire Merck, March 8, 2013 Free full text
12 Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan Teva Pharmaceutical Industries, April 10, 2013 Free full text
13 Astellas pharma global development announces management reorganization Astellas, April 3, 2013 Free full text
14 Covidien Announces Nominees to Board of Directors for Mallinckrodt Pharmaceutical Business Covidien, March 18, 2013
15 Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan Teva Pharmaceutical Industries, April 9, 2013 Free full text
16 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 9, 2013 Free full text
17 Bristol-Myers Squibb Announces Appointment of Francis Cuss as Executive Vice President and Chief Scientific Officer, Effective July 1; Elliott Sigal Plans to Retire Bristol Myers-Squibb, April 8, 2013 Free full text
18 Definiens Appoints Chief Marketing Officer, Merrilyn Datta, Ph.D. B3C newswire, April 10, 2013 Free full text
19 Bristol-Myers Squibb Appoints Ann Powell Judge Senior Vice President, Human Resources Bristol Myers-Squibb, March 5, 2013 Free full text
20 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries, April 10, 2013 Free full text
Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close